EXALENZ BIOSCIENCE (Israel) Performance

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>EXE</div>
The firm owns Beta (Systematic Risk) of 0.0 which denotes to the fact that the returns on MARKET and EXALENZ BIOSCIENCE are completely uncorrelated. Although it is extremely important to respect EXALENZ BIOSCIENCE existing price patterns, it is better to be realistic regarding the information on equity price patterns. The approach towards predicting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing EXALENZ BIOSCIENCE technical indicators you can today evaluate if the expected return of 0.0% will be sustainable into the future. EXALENZ BIOSCIENCE now owns a risk of 0.0%. Please confirm EXALENZ BIOSCIENCE Semi Deviation, Coefficient Of Variation and the relationship between Mean Deviation and Downside Deviation to decide if EXALENZ BIOSCIENCE will be following its current price history.
00

Risk-Adjusted Performance

Over the last 30 days EXALENZ BIOSCIENCE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, EXALENZ BIOSCIENCE is not utilizing all of its potentials. The current stock price disturbance, may contribute to short term losses for the investors.
Quick Ratio1.02
Fifty Two Week Low440.20
Fifty Two Week High1,455.00
Horizon     30 Days    Login   to change

EXALENZ BIOSCIENCE Relative Risk vs. Return Landscape

If you would invest  0.00  in EXALENZ BIOSCIENCE on December 25, 2019 and sell it today you would earn a total of  0.00  from holding EXALENZ BIOSCIENCE or generate 0.0% return on investment over 30 days. EXALENZ BIOSCIENCE is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than EXALENZ BIOSCIENCE and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
    
  Risk (%) 

EXALENZ BIOSCIENCE Market Risk Analysis

Sharpe Ratio = 0.0
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
EXEN
Based on monthly moving average EXALENZ BIOSCIENCE is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EXALENZ BIOSCIENCE by adding it to a well-diversified portfolio.

EXALENZ BIOSCIENCE Alerts

Equity Alerts and Improvement Suggestions

EXALENZ BIOSCIENCE is not yet fully synchronised with the market data
EXALENZ BIOSCIENCE has some characteristics of a very speculative penny stock
EXALENZ BIOSCIENCE has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 13.25 M. Net Loss for the year was (5.29 M) with profit before overhead, payroll, taxes, and interest of 5.75 M.
EXALENZ BIOSCIENC has accumulated about 2.96 M in cash with (5.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
See also Investing Opportunities. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Company logos by clearbit